Thinking of joining a study?

Register your interest

NCT05365243 | Withdrawn | Alopecia


A Pilot Study to Evaluate the Use of the AMMA Portable Scalp Cooling System From Cooler Heads
Sponsor:

Cooler Heads Care Inc.

Brief Summary:

Eligible patients will be recruited prior to initiation of chemotherapy for any stage breast or gynecologic cancer. Patients will undergo training in the use of the AMMA Portable Scalp Cooling System and will use the device during each of their chemotherapy treatments. Quality of life and experience of use questionnaires will be completed. Scalp photos and an assessment of hair loss will be preformed at enrollment and at the end of study participation.

Condition or disease

Alopecia

Chemotherapy-induced Alopecia

Hair Loss

Breast Cancer

Gynecologic Cancer

Intervention/treatment

AMMA Portalbe Scalp Cooling System

Phase

Not Applicable

Detailed Description:

AMMA is designed to be used by patients in the chemotherapy infusion center, during transport from the infusion center to home, and after arrival at home. Patients will participate in training in AMMA use and will be asked to bring the device to the chemotherapy infusion center for use during each chemotherapy treatment visit. The device will be used for 30 minutes prior to the start of chemotherapy, during chemotherapy and for 2 hours after chemotherapy. Scalp photos will be obtained at baseline and after the last chemotherapy treatment. Patients will be asked to complete the following questionnaires: training evaluation after training is complete; and symptoms from device use, experience with device use and self-assessment of hair loss after each chemotherapy treatment.

Study Type : Interventional
Estimated Enrollment : 0 participants
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: A Pilot Study to Evaluate the Use of the AMMA Portable Scalp Cooling System
Actual Study Start Date : August 15, 2022
Estimated Primary Completion Date : June 30, 2023
Estimated Study Completion Date : September 30, 2023
Arm Intervention/treatment

Experimental: Interventional

All patients will use AMMA

Device: AMMA Portalbe Scalp Cooling System

Ages Eligible for Study: 21 Years
Sexes Eligible for Study: Female
Accepts Healthy Volunteers: No
Criteria
Inclusion Criteria
  • Female age 21 years or older at the time of signing informed consent.
  • Documented pathologic diagnosis of invasive breast or gynecologic cancer, any stage, requiring treatment with a taxane-containing chemotherapy regimen
  • Planned start of treatment with taxane-based chemotherapy in the adjuvant, neoadjuvant or advanced setting
  • Plan to complete chemotherapy within 6 months of treatment start
  • If received prior chemotherapy causing hair loss, >/= 2 years since last chemotherapy dose and complete recovery of hair
  • ECOG performance status 0-1
  • Willing and able to sign informed consent for study procedures
  • Willing and able to participate in all study procedures
Exclusion Criteria
  • Plan to use chemotherapy regimen other than that listed in inclusion criteria, including any anthracycline-based regimen
  • Plan to initiate bone marrow ablation chemotherapy
  • History of or plan to initiate whole or partial brain or skull irradiation
  • Hormone therapy concurrent with current chemotherapy regimen
  • Existing or suspected scalp metastases
  • History of concomitant diagnosis of: autoimmune disease affecting hair; cryoglobulinemia; untreated iron deficiency with or without anemia; cold agglutination disease; post-traumatic cold dystrophy; untreated or poorly controlled hyper- or hypothyroidism
  • Female pattern baldness
  • History of persistent chemotherapy-induced alopecia from prior chemotherapy
  • Concomitant exposure to investigational agents, drugs, devices or procedures that cause hair loss
  • Concomitant other solid tumor or hematologic malignancy in addition to the current diagnosis

A Pilot Study to Evaluate the Use of the AMMA Portable Scalp Cooling System From Cooler Heads

Location Details


Please Choose a site



A Pilot Study to Evaluate the Use of the AMMA Portable Scalp Cooling System From Cooler Heads

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


Not yet recruiting

United States, New York

White Plains Hospital

White Plains, New York, United States, 10601

Loading...